Athabasca Oil (ATH) PT Raised to C$2.50 at Raymond James

Athabasca Oil (TSE:ATH) had its price objective hoisted by Raymond James from C$2.00 to C$2.50 in a research report released on Tuesday morning.

Other research analysts also recently issued research reports about the company. GMP Securities increased their price objective on Athabasca Oil from C$1.65 to C$2.25 in a report on Tuesday, May 15th. TD Securities upped their target price on Athabasca....More>>>

Strategies For Maximizing Your Social Security Benefits

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-750367222&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/750367222/960×0.jpg?fit=scale&q; data-height=&q;663&q; data-width=&q;960&q;&g; Shutterstock

&l;em&g;This is the third post in a three-part series that discusses important considerations regarding Social Security benefits and strategies for incorporating....More>>>

Devon Energy (DVN) Stake Boosted by Anchor Capital Advisors LLC

Anchor Capital Advisors LLC grew its position in shares of Devon Energy (NYSE:DVN) by 0.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 392,306 shares of the energy company’s stock after acquiring an additional 3,119 shares during the period. Anchor Capital Advisors LLC’s holdings in Devon....More>>>

Top 10 Stocks For 2019

(Post Fed Announcement) There’s not much to see here folks. The Federal Reserve appears to have become a master of telegraphing its message to the markets and investors well ahead of announcing its interest-rate “decision” and showcased that again today when it said that it would keep the Federal funds rates in a range of 1% to 1.25%.

What did change in its statement is....More>>>

Amgen (AMGN) Given Consensus Recommendation of “Hold” by Analysts

Shares of Amgen (NASDAQ:AMGN) have earned an average recommendation of “Hold” from the twenty-seven research firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and ten have given a buy rating to the company. The average 1 year target price among brokers that have issued....More>>>